NPS Pharmaceuticals Inc. (NPSP) Stock Quote

Detailed Quote for NPS Pharmaceuticals Inc. (NPSP) 
$ 6.69   -0.09 (-1.33%) Volume: 26.78 k 10:34 AM EDT Sep 2, 2010
Today 5d 1m 3m 1y more
Last Price
6.69
Change $
0.09
Change %
1.33%
Tick
  
Bid
6.68
Bid Size
100
Ask
6.69
Ask Size
2800
Open
6.75
High
6.75
Low
6.533
Prev Close
6.78
Last Trade
10:34
Volume
26.78 k
52 Wk Hi
7.75
52 Wk Low
0.01
Market Cap
394.52 m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
58,970,925
EPS (TTM)
-0.37
PE Ratio
N/A
Exchange
NSD
News and Media for NPS Pharmaceuticals Inc.  (NPSP) 
Sector News | Topic News
News for NPSP
Wed, Aug 04, 2010
4:30 PM NPS Pharmaceuticals Reports Second Quarter 2010 Financial Results and Two Phase 3 Registration Programs on Track with Stated Timelines - Business Wire
Thu, Jul 29, 2010
4:10 PM NPS Pharmaceuticals to Present at Upcoming Conferences - Business Wire
Wed, Jul 28, 2010
4:10 PM NPS Pharmaceuticals to Report Second Quarter 2010 Financial Results - Business Wire
Thu, Jul 22, 2010
9:14 AM NPS Pharmaceuticals Announces Completion of Patient Randomization in Phase 3 STEPS Study of GATTEX(R) in Short Bowel Syndrome - Business Wire
Thu, Jun 10, 2010
4:10 PM NPS Pharmaceuticals to Present at ThinkEquity Healthcare Conference - Business Wire
Tue, Jun 17, 2008
8:59 AM Medicis to Acquire LipoSonix and NPS Pharmaceuticals Notified of ANDA Filings for Cinacalcet HCl - Financial News USA
Thu, May 08, 2008
11:29 AM Neurobiological Technologies Sets Date for Third Quarter Financial Results and GATTEX(TM) Abstracts Accepted for Presentation at DDW Conference; Phase 3 Short Bowel Syndrome Results Scheduled for Oral Plenary Session and GATTEX(TM) Abstracts Accepted for Presentation at DDW Conference; Phase 3 Short Bowel Syndrome Results Scheduled for Oral Plenary Session - Financial News USA
Mon, Mar 17, 2008
4:01 PM NPS Reports Successful GATTEX(TM) Extension Study - Canada Newswire
Thu, Mar 13, 2008
4:39 PM NPS Pharmaceuticals Reports 2007 Financial Results - Canada Newswire
Thu, Mar 06, 2008
5:01 PM NPS Pharmaceuticals to Report 2007 Financial Results - Canada Newswire
Fri, Feb 29, 2008
2:06 PM NPS Pharmaceuticals to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference - Canada Newswire
Tue, Feb 26, 2008
9:06 AM NPS Pharmaceuticals Announces Senior Management Changes - Canada Newswire
Mon, Feb 04, 2008
5:04 PM NPS Pharmaceuticals to Present at BIO CEO & Investor Conference - Canada Newswire
Wed, Jan 30, 2008
8:31 AM NPS Pharmaceuticals Announces Board Appointments - Canada Newswire
Mon, Jan 28, 2008
4:31 PM NPS Pharmaceuticals Provides Update on GATTEX(TM) Clinical Development in Short Bowel Syndrome - Canada Newswire
Wed, Jan 02, 2008
11:45 AM NPS Pharmaceuticals Appoints Dr. Alan G. Harris Chief Medical Officer - Canada Newswire
Fri, Dec 21, 2007
3:26 PM NPS Pharmaceuticals to Present at the JPMorgan 26th Annual Healthcare Conference on January 9, 2008 - Canada Newswire
Tue, Nov 13, 2007
4:37 PM NPS Pharmaceuticals Announces Senior Management Appointments - Canada Newswire
Fri, Nov 02, 2007
8:31 AM NPS Pharmaceuticals to Webcast Presentation at CIBC World Markets 18th Annual Healthcare Conference - Canada Newswire
Thu, Nov 01, 2007
4:45 PM NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance - Canada Newswire
More News for NPSP >>

Tags for NPS Pharmaceuticals Inc.

Research stocks or mutual funds related to NPS Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to NPSP. The keywords below have been associated to NPSP by either user submission or electronic means.

schering plough health care products biotechnology company pharmaceuticals research pharmaceuticals international research king report on corporate governance corporate governance quotient elite pharmaceuticals pharmaceutical industry strategy biotech conference pharmaceutical market corporate governance consulting corporate governance training pharmaceuticals companies generic pharmaceutical pharmaceuticals logistics niche pharmaceutical investment products board of director biotechnology market pharmaceutical research and development corporate governance legislation annual report corporate governance committee charter new innovative products Biological Products corporate governance calpers corporate governance governance consultant pharma manufacturing governance consulting corporate governance practices pharmaceuticals jobs pfizer pharmaceutical company novartis pharmaceuticals kv pharmaceutical company pharmaceuticals supply chain corporate law warrick pharmaceutical corporate governance issues licensed products generic products corporate governance conference corporate governance ratings data monitoring committees pharmaceutical cro annual report printing pharma companies define corporate governance governance policy board of directors role

 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.